Healthtech is advancing at a remarkable pace, but true impact happens when science, business, and patient needs align. With more than two decades at this intersection—beginning in chemistry and toxicology research and evolving into executive leadership—I’ve seen firsthand that the best leaders are translators. By turning complex discoveries into practical solutions, I’ve helped scale enterprises, launch new diagnostics, and guide innovation from the lab bench to the marketplace. The future of healthtech depends not just on discovery, but on disciplined leadership that bridges vision with execution, ensuring breakthroughs reach the patients who need them most.

I’m excited to share a glimpse into my professional journey and achievements. With a Ph.D. in Immunology from the Hebrew University of Jerusalem and extensive experience at the National Institute of Allergy and Infectious Diseases (NIAID), I’ve had the privilege of leading transformative research in cancer immunotherapy and PET imaging of cancer biomarkers. My work has focused on advancing personalized medicine and targeted therapies, and I’m passionate about driving innovation in these fields. I invite you to explore my career highlights and contributions, which reflect my commitment to impactful research and visionary leadership. Thank you for your support and interest!